Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
417K
-
Shares change
-
+99.3K
-
Total reported value, excl. options
-
$2.93M
-
Value change
-
+$715K
-
Number of buys
-
5
-
Number of sells
-
-3
-
Price
-
$7.01
Significant Holders of Lexaria Bioscience Corp. - COM NEW (LEXX) as of Q2 2021
11 filings reported holding LEXX - Lexaria Bioscience Corp. - COM NEW as of Q2 2021.
Lexaria Bioscience Corp. - COM NEW (LEXX) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 417K shares
.
Largest 10 shareholders include Invenomic Capital Management LP (317K shares), GEODE CAPITAL MANAGEMENT, LLC (50.4K shares), VANGUARD GROUP INC (26K shares), RENAISSANCE TECHNOLOGIES LLC (17.2K shares), Edge Wealth Management LLC (3.33K shares), MD Financial Management Inc. (2.69K shares), ROYAL BANK OF CANADA (254 shares), Tower Research Capital LLC (TRC) (230 shares), OSAIC HOLDINGS, INC. (166 shares), and CITADEL ADVISORS LLC (0 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.